SCHEMBL18800786

SCHEMBL18800786

COc1cccc(-c2cnc(Nc3c(C)cc(C)cc3C)c(N)c2C(=N)N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 1/20 0.44
▸ SRC P12931 3/20 0.43
▸ DHODH Q02127 3/20 0.42
▸ BTK Q06187 2/20 0.42
▸ ADORA2A P29274 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ CYP1A2 P05177 3/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ CYP2C19 P33261 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TDO2 P48775 1/20 0.39
▸ PDGFRB P09619 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800466 0.88 DHODH (0.42) SRCDHODHBTKADORA2AADORA1
SCHEMBL18800468 0.86 BTK (0.49) SRCDHODHBTKADORA2AADORA1
SCHEMBL18800563 0.85 BTK (0.58) BTKADORA2AADORA1CYP1A2CYP3A4
SCHEMBL18800760 0.81 BTK (0.61) SRCDHODHBTKADORA2AADORA1
SCHEMBL18800792 0.77 BTK (0.47) DHODHBTKADORA2AADORA1PDGFRB
SCHEMBL18800891 0.76 BTK (0.62) DHODHBTKADORA2AADORA1ALDH1A1
SCHEMBL8402333 0.75 BTK (0.74) RAPGEF4SRCDHODHBTKADORA2A
SCHEMBL18800784 0.75 BTK (0.46) DHODHBTKADORA2AADORA1
SCHEMBL18800559 0.74 BTK (0.58) SRCBTKMAPK1ALDH1A1MEN1
SCHEMBL18800772 0.74 ADORA1 (0.43) SRCBTKADORA1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback